Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut
Rain Oncology Inc RAIN has agreed to be acquired by Pathos AI Inc. for $1.16 in cash per share plus a non-tradeable contingent value right (CVR) for potential…
Source: biztoc.com
Stay updated with breaking news from Brain Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rain Oncology Inc RAIN has agreed to be acquired by Pathos AI Inc. for $1.16 in cash per share plus a non-tradeable contingent value right (CVR) for potential…
Rain Oncology Inc (NASDAQ: RAIN) has agreed to be acquired by Pathos AI Inc.
NEWARK, Calif., Dec. 13, 2023 -- Rain Oncology Inc. , today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. will acquire Rain for $1.16 in cash per share plus...